Clinical trial
An Extension Phase II Study of the Clinical and Biologic Effects of Docetaxel (Taxotere) in Patients With Locally Advanced Breast Cancer
NCT00206453 is registered in ClinicalTrials.gov with Baylor Breast Care Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Extension Phase II Study of the Clinical and Biologic Effects of Docetaxel (Taxotere) in Patients With Locally Advanced Breast Cancer
- Lead sponsor
- Baylor Breast Care Center
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- January 31, 2002
- Completion date
- January 31, 2005
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer